Cardio Diagnostics Holdings (CDIO) EPS (Basic) Growth (3y) (2024 - 2026)

Cardio Diagnostics Holdings (CDIO) EPS (Basic) Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.78 Bn	131.92 Bn	2.84 Bn	6.85%
2	Regeneron Pharmaceuticals	86.56 Bn	78.57 Bn	3.93 Bn	11.71%
3	Argenx Se	65.48 Bn	60.29 Bn	1.37 Bn	64.84%
4	Moderna	59.12 Bn	53.98 Bn	52.00 Mn	18.44%
5	BeOne Medicines	42.10 Bn	37.00 Bn	1.53 Bn	37.21%
6	Alnylam Pharmaceuticals	31.75 Bn	28.45 Bn	992.69 Mn	36.73%
7	BioNTech SE	28.12 Bn	9.72 Bn	668.28 Mn	-26.87%
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	67.51%
9	Royalty Pharma	27.20 Bn	26.36 Bn	-	-38.31%
10	Cardio Diagnostics Holdings	6.10 Mn	509,808.97	-	64.95%

Download Data